Philippe Pouletty is a director and executive associated with Truffle Capital Sas, a French investment firm with significant influence over Affluent Medical. Due to his senior position providing access to material non-public information, he is subject to mandatory transaction disclosure obligations under EU Market Abuse Regulation requirements.
Rendement 1 an
+29.5%
Historique des transactions
1
Historique des transactions
1 transaction signalCôté